Induction of squamous cell carcinoma in p53-deficient mice after ultraviolet irradiation

被引:79
作者
Li, G
Tron, V
Ho, V
机构
[1] Univ British Columbia, Vancouver Hosp & Hlth Sci Ctr, Dept Med, Div Dermatol, Vancouver, BC, Canada
[2] Univ British Columbia, Vancouver Hosp & Hlth Sci Ctr, Dept Pathol, Vancouver, BC, Canada
关键词
D O I
10.1046/j.1523-1747.1998.00090.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Mutations of the p53 gene have been implicated as an important factor in the pathogenesis of ultraviolet light induced skin cancers. To examine the role of p53 in skin carcinogenesis, we observed the development of skin cancers in homozygous p53-deficient (-/-) mice and wild-type p53 (+/+) mice, after chronic ultraviolet B (290-320 nm) exposure. At a dose of 2 J per m(2) per s of ultraviolet B for 30 min three times per week, all p53(-/-) mice developed skin tumors by week 12. All the p53(-/-) mice developed multiple tumors by week 16. The majority of the tumors occurred on the ears. None of the p53(+/+) mice developed skin tumors after 17 wk of UV exposure. Ten p53(-/-) tumors were examined histologically: five invasive squamous cell carcinomas, four cell carcinomas in situ, and one actinic p53(-/-) mice have a short life-span due to internal turners or a deficiency in the immune system; however, ultraviolet B exposure did not significantly reduce the life-span of p53(-/-) mice. These results demonstrate that loss of wild-type p53 function shortens the latent period and predisposes the animals to the development of squamous cell carcinomas after ultraviolet irradiation.
引用
收藏
页码:72 / 75
页数:4
相关论文
共 38 条
[11]   DOWN-REGULATION OF WILD-TYPE P53 ACTIVITY INTERFERES WITH APOPTOSIS OF IL-3-DEPENDENT HEMATOPOIETIC-CELLS FOLLOWING IL-3 WITHDRAWAL [J].
GOTTLIEB, E ;
HAFFNER, R ;
VONRUDEN, T ;
WAGNER, EF ;
OREN, M .
EMBO JOURNAL, 1994, 13 (06) :1368-1374
[12]  
HALL PA, 1993, ONCOGENE, V8, P203
[13]  
HARPER JW, 1993, CELL, V75, P805
[14]   A MUTANT P53 TRANSGENE ACCELERATES TUMOR-DEVELOPMENT IN HETEROZYGOUS BUT NOT NULLIZYGOUS P53 DEFICIENT MICE [J].
HARVEY, M ;
VOGEL, H ;
MORRIS, D ;
BRADLEY, A ;
BERNSTEIN, A ;
DONEHOWER, LA .
NATURE GENETICS, 1995, 9 (03) :305-311
[15]   P53 MUTATIONS IN HUMAN CANCERS [J].
HOLLSTEIN, M ;
SIDRANSKY, D ;
VOGELSTEIN, B ;
HARRIS, CC .
SCIENCE, 1991, 253 (5015) :49-53
[16]  
KANJILAL S, 1993, CANCER RES, V53, P2961
[17]   NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].
KAPLAN, EL ;
MEIER, P .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481
[18]   A MAMMALIAN-CELL CYCLE CHECKPOINT PATHWAY UTILIZING P53 AND GADD45 IS DEFECTIVE IN ATAXIA-TELANGIECTASIA [J].
KASTAN, MB ;
ZHAN, QM ;
ELDEIRY, WS ;
CARRIER, F ;
JACKS, T ;
WALSH, WV ;
PLUNKETT, BS ;
VOGELSTEIN, B ;
FORNACE, AJ .
CELL, 1992, 71 (04) :587-597
[19]  
KASTAN MB, 1991, CANCER RES, V51, P6304
[20]   OZONE DEPLETION AND INCREASE IN ANNUAL CARCINOGENIC ULTRAVIOLET DOSE [J].
KELFKENS, G ;
DEGRUIJL, FR ;
VANDERLEUN, JC .
PHOTOCHEMISTRY AND PHOTOBIOLOGY, 1990, 52 (04) :819-823